83 master-"https:" "https:" "https:" "https:" "UCL" "UCL" uni jobs at Nature Careers in Germany
Sort by
Refine Your Search
-
Area of research: Diploma & Master Thesis Job description: Master's Thesis – Nanocarrier Development for Immune Cell Targeting (f/m/x) 102909 Part time 20 hrs./week Neuherberg near Munich Partial
-
Temporary: Initially limited to one year with the possibility of a fixed term in the case of probation Remuneration: TV-L 14 Start: as soon as possible As part of the new Master's degree in "Clinical
-
Fighting pathogens together! Chief Core Facilities Officer (f/m/d) Job advertisement no. : 589 Starting date: As soon as possible Duration of employment: Initially limited to 5 years. Long-term
-
The Center for Molecular Bioengineering (B CUBE) is an interdisciplinary research center focusing on three research dimensions: Bio-prospecting, BioNano Tools, and Biomimetic Materials (see https
-
, epidemiology, public health, pharmacogenetics, medicine, pharmacology, pharmacy), with a main focus on the use and analysis of large amounts of data throughout the life cycle of pharmaceuticals. The spectrum
-
with the University of Hohenheim and Senckenberg - Leibniz Institution for Biodiversity and Earth System Research (https://www.terra-cluster.org ). TERRA will develop an integrated understanding of how
-
with a certified serious disability and those of equal status are particularly welcome. Qualified candidates are asked to apply via the Appointment Portal of the University of Bonn (https
-
serious disability and those of equal status are particularly welcome. Qualified candidates are asked to apply via the Academic Appointment Portal of the University of Bonn (https://berufungsportal.uni
-
https://securemail.tu-dresden.de by sending it as a single pdf file tojobs-scads.ai@tu-dresden.de or to: TU Dresden, ScaDS.AI, Prof. Dr.-Ing. Michael Färber, Helmholtzstr. 10, 01069 Dresden, Germany
-
is a recognized leader in clinical cancer epidemiology. The successful candidate is expected to pursue highly original and innovative research at the frontiers of risk-adapted early cancer detection